Does T1c–2N0–1M0 triple negative breast cancer derive a benefit from neoadjuvant chemotherapy?
2024 · European journal of medical research · 3 citations
https://doi.org/10.1186/s40001-024-02139-1
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
19
Papers
89
Citations
6
h-index
1
i10-index
Wenfen Fu is an academic researcher from Fujian Medical University. The author has contributed to research in topics: Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research & Estrogen and related hormone effects. The author has an h-index of 6, co-authored 17 publications.
https://doi.org/10.1186/s40001-024-02139-1
https://doi.org/10.1186/s12885-023-11722-4
Click to start Chat